4.7 Article

Anticancer and Structure Activity Relationship of Non-Symmetrical Choline Kinase Inhibitors

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Chemistry, Physical

Delivery of repurposed disulfiram by aminated mesoporous silica nanoparticles for anticancer therapy

Md Aquib et al.

Summary: Aminated mesoporous silica nanoparticles (AMPSNPs) were developed as a nanocarrier for disulfiram (DSF) delivery in cancer therapies. The optimized AMPSNPs showed excellent properties and compatibility, providing potential for effective drug delivery.

JOURNAL OF MOLECULAR LIQUIDS (2022)

Review Chemistry, Medicinal

Recent advances in the design of choline kinase α inhibitors and the molecular basis of their inhibition

Belen Rubio-Ruiz et al.

Summary: Upregulated choline metabolism, characterized by an increase in phosphocholine (PCho), is a hallmark of oncogenesis and tumor progression. Choline kinase (ChoK), the enzyme responsible for PCho synthesis, has consequently become a promising drug target for cancer therapy and as such a significant number of ChoK inhibitors have been developed over the last few decades. Additionally, due to the role of this enzyme in other pathologies, ChoK inhibitors have also been used in new therapeutic approaches against malaria and rheumatoid arthritis.

MEDICINAL RESEARCH REVIEWS (2021)

Review Engineering, Biomedical

Recent Advances in Cell Membrane-Derived Biomimetic Nanotechnology for Cancer Immunotherapy

Faisal Raza et al.

Summary: Immunotherapy in cancer treatment is being significantly impacted by advancements in biomimetic nanotechnology. The challenges surrounding cancer nanomedicine have led to a push for innovative approaches, such as biomimetic nanoparticles, to improve the delivery and effectiveness of immunotherapeutics for cancer. These strategies show promise in addressing issues related to the tumor microenvironment, patient heterogeneity, and immunotoxicity.

ADVANCED HEALTHCARE MATERIALS (2021)

Review Pharmacology & Pharmacy

Choline Kinase: An Unexpected Journey for a Precision Medicine Strategy in Human Diseases

Juan Carlos Lacal et al.

Summary: Choline kinase plays a crucial role in human tumors and specific compounds targeting it have been identified as potential anticancer agents. Some of these compounds have shown selective anticancer activity and have progressed to clinical trials. Additionally, ChoK alpha inhibitors are proposed as a novel therapeutic approach against various diseases.

PHARMACEUTICS (2021)

Review Pharmacology & Pharmacy

ChoK-Full of Potential: Choline Kinase in B Cell and T Cell Malignancies

Samantha Gokhale et al.

Summary: Aberrant choline metabolism, particularly involving overexpression of choline kinase alpha (CHKα), is a metabolic hallmark of carcinogenesis and tumor progression. Non-invasive imaging techniques such as MRS and PET/CT, utilizing radiolabeled choline analogs, can detect increased choline metabolism and CHKα activity, providing valuable diagnostic and monitoring tools for cancer patients.

PHARMACEUTICS (2021)

Review Materials Science, Biomaterials

Recent progress on nanomedicine-induced ferroptosis for cancer therapy

Hajra Zafar et al.

Summary: Ferroptosis, a form of non-apoptotic cell death, shows potential in eliminating aggressive malignancies resistant to traditional therapies. The combination of nanomedicine and ferroptosis has shown efficacy in treating various types of cancer.

BIOMATERIALS SCIENCE (2021)

Article Multidisciplinary Sciences

Choline kinase inhibitors EB-3D and EB-3P interferes with lipid homeostasis in HepG2 cells

Alberto Sola-Leyva et al.

SCIENTIFIC REPORTS (2019)

Article Chemistry, Medicinal

New more polar symmetrical bipyridinic compounds: new strategy for the inhibition of choline kinase α1

Francisco Fermin Castro-Navas et al.

FUTURE MEDICINAL CHEMISTRY (2015)

Article Chemistry, Multidisciplinary

The Mechanism of Allosteric Coupling in Choline Kinase1 Revealed by the Action of a Rationally Designed Inhibitor

Maria Sahun-Roncero et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2013)

Article Biochemistry & Molecular Biology

New non-symmetrical choline kinase inhibitors

Santiago Schiaffino-Ortega et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2013)

Article Biochemistry & Molecular Biology

Determination of Potential Scaffolds for Human Choline Kinase 1 by Chemical Deconvolution Studies

Maria Sahun-Roncero et al.

CHEMBIOCHEM (2013)

Article Chemistry, Medicinal

Design, synthesis, theoretical calculations and biological evaluation of new non-symmetrical choline kinase inhibitors

Belen Rubio-Ruiz et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)

Article Multidisciplinary Sciences

Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion

Ravid Straussman et al.

NATURE (2012)

Article Biochemistry & Molecular Biology

The Kennedy pathway-De novo synthesis of phosphatidylethanolamine and phosphatidylcholine

Federica Gibellini et al.

IUBMB LIFE (2010)

Review Biochemistry & Molecular Biology

Structure and function of pho sphatidylcho line transfer protein (PC-TP)/StarD2

Keishi Kanno et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2007)

Article Biochemistry & Molecular Biology

Surflex-Dock 2.1: Robust performance from ligand energetic modeling, ring flexibility, and knowledge-based search

Ajay N. Jain

JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2007)

Review Biochemistry & Molecular Biology

Choline kinase: An important target for cancer

S Janardhan et al.

CURRENT MEDICINAL CHEMISTRY (2006)

Article Chemistry, Organic

Conformational dynamics of a bispyridinium cyclophane

A Conejo-García et al.

JOURNAL OF ORGANIC CHEMISTRY (2003)